REGN R&D Expense Growth
Regeneron Pharmaceuticals · R&D Expense Growth
REGN R&D Expense Growth
Latest reported11.79%period ending
REGN FY R&D Growth (YoY) (0.00% → 11.79%)
Latest values, visible window
High-resolution chart · PNG
REGN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 11.7944% | |
| 31.2614% | |
| 30.4506% | |
| 16.5605% | |
| 4.9138% | |
| 11.5819% | |
| 9.9024% | |
| 5.6085% | |
| -0.9178% | |
| 26.0005% | |
| 26.8327% | |
| 48.8461% | |
| 39.0968% | |
| 18.095% | |
| 6.1459% | |
| 22.1188% | |
| 44.1594% | |
| 40.2906% | |
| 55.6853% | |
| -11.4558% | |
| 1.3424% | |
| 0.0522% | |
| 8.8837% | |
| 36.4715% | |
| 62.7204% | |
| 25.2918% | |
| 21.3514% | |
| 33.0935% | |
| -1.7668% | |
| 21.4592% | |
| -41.3098% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |